NCT06462092 2025-09-29Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast CancerGuangzhou Medical UniversityPhase 1/2 Recruiting34 enrolled
NCT05315700 2025-08-05Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationORIC PharmaceuticalsPhase 1/2 Recruiting350 enrolled